Summary
CCP Technologies Ltd (CCP), formerly Agenix Ltd is a biotechnology company that offers molecule drugs. The company develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of various diseases. It develops DiagnostIQ rapid point-of-care human diagnostic technology and Thromboview patented technetium-99m-labelled antibody based radio-imaging test for venous thromboembolism (VTE). Agenix’s thromboembolism are used in test for conditions which include pulmonary embolism (PE), upper extremity venous thromboembolism (UEVTE) and deep vein thrombosis (DVT), among others. The company develops hand-held cassette technology that used in non-instrumented qualitative testing devices. CCP is headquartered in Broadbeach, Queensland, Australia.
CCP Technologies Ltd (AGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CCP Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CCP Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Agenix To Divest AGX-1009 To Chinese Pharma Company 11
Equity Offering 11
Agenix Completes Private Placement Of Shares For US$0.78 Million 11
Agenix Completes Rights Offering Of Shares For US$1.3 Million 12
Agenix Completes First Tranche Of Private Placement Of Shares For US$0.06 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 15
Debt Offering 16
Agenix Announces Private Placement Of Notes Due 2013 For US$0.2 Million 16
CCP Technologies Ltd - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Tables
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CCP Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CCP Technologies Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
CCP Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Agenix To Divest AGX-1009 To Chinese Pharma Company 11
Agenix Completes Private Placement Of Shares For US$0.78 Million 11
Agenix Completes Rights Offering Of Shares For US$1.3 Million 12
Agenix Completes First Tranche Of Private Placement Of Shares For US$0.06 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 14
Agenix Completes Private Placement Of Shares For US$0.1 Million 15
Agenix Announces Private Placement Of Notes Due 2013 For US$0.2 Million 16
CCP Technologies Ltd, Key Competitors 18
CCP Technologies Ltd, Key Employees 19
List of Figures
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CCP Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CCP Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 9